Yu S, Yang S, Hu L, Duan W, Zhao T, Qin Y
Ann Hematol. 2025; .
PMID: 39966122
DOI: 10.1007/s00277-024-06182-0.
Shen J, Shan M, Chu M, Cai Y, Rui J, Chen S
Blood Cancer J. 2025; 15(1):17.
PMID: 39934109
PMC: 11814316.
DOI: 10.1038/s41408-025-01227-7.
Stanland L, Ang H, Hoj J, Chu Y, Tan P, Wood K
Mol Cancer Res. 2023; 21(11):1148-1162.
PMID: 37493631
PMC: 10811747.
DOI: 10.1158/1541-7786.MCR-23-0034.
Medina E, Delma C, Yang F
J Hematol Oncol. 2022; 15(1):127.
PMID: 36068610
PMC: 9450349.
DOI: 10.1186/s13045-022-01336-x.
Zhang R, Zhang Y, Lu X, Xu W, Wang H, Mo W
Front Oncol. 2020; 10:204.
PMID: 32175275
PMC: 7056905.
DOI: 10.3389/fonc.2020.00204.
Acute myeloid leukemia with inv(16)(p13.1q22) and deletion of the 5'MYH11/3'CBFB gene fusion: a report of two cases and literature review.
Lv L, Yu J, Qi Z
Mol Cytogenet. 2020; 13:4.
PMID: 32015759
PMC: 6990480.
DOI: 10.1186/s13039-020-0474-9.
The combination of FLT3 and SYK kinase inhibitors is toxic to leukaemia cells with CBL mutations.
Weisberg E, Meng C, Case A, Tiv H, Gokhale P, Toure A
J Cell Mol Med. 2020; 24(3):2145-2156.
PMID: 31943762
PMC: 7011134.
DOI: 10.1111/jcmm.14820.
Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU-285 on oncogenic mutants of KIT, CBL and FLT3 in haematological malignancies.
Weisberg E, Meng C, Case A, Sattler M, Tiv H, Gokhale P
Br J Haematol. 2019; 187(4):488-501.
PMID: 31309543
PMC: 7887860.
DOI: 10.1111/bjh.16092.
IL1RL1 is dynamically expressed on Cbfb-MYH11 leukemia stem cells and promotes cell survival.
Wang Y, Richter L, Becker M, Amador C, Hyde R
Sci Rep. 2019; 9(1):1729.
PMID: 30742053
PMC: 6370767.
DOI: 10.1038/s41598-018-38408-3.
Phase II Trial of MEK Inhibitor Binimetinib (MEK162) in RAS-mutant Acute Myeloid Leukemia.
Maiti A, Naqvi K, Kadia T, Borthakur G, Takahashi K, Bose P
Clin Lymphoma Myeloma Leuk. 2019; 19(3):142-148.e1.
PMID: 30635233
PMC: 11852403.
DOI: 10.1016/j.clml.2018.12.009.
Preleukemia and Leukemia-Initiating Cell Activity in inv(16) Acute Myeloid Leukemia.
Pulikkan J, Castilla L
Front Oncol. 2018; 8:129.
PMID: 29755956
PMC: 5932169.
DOI: 10.3389/fonc.2018.00129.
Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.
Gao Q, Liang W, Foltz S, Mutharasu G, Jayasinghe R, Cao S
Cell Rep. 2018; 23(1):227-238.e3.
PMID: 29617662
PMC: 5916809.
DOI: 10.1016/j.celrep.2018.03.050.
Intergenically Spliced Chimeric RNAs in Cancer.
Jia Y, Xie Z, Li H
Trends Cancer. 2017; 2(9):475-484.
PMID: 28210711
PMC: 5305119.
DOI: 10.1016/j.trecan.2016.07.006.
The genomic landscape of core-binding factor acute myeloid leukemias.
Faber Z, Chen X, Gedman A, Boggs K, Cheng J, Ma J
Nat Genet. 2016; 48(12):1551-1556.
PMID: 27798625
PMC: 5508996.
DOI: 10.1038/ng.3709.
Subtype-specific patterns of molecular mutations in acute myeloid leukemia.
Rose D, Haferlach T, Schnittger S, Perglerova K, Kern W, Haferlach C
Leukemia. 2016; 31(1):11-17.
PMID: 27285584
DOI: 10.1038/leu.2016.163.
Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignancies.
Borthakur G, Popplewell L, Boyiadzis M, Foran J, Platzbecker U, Vey N
Cancer. 2016; 122(12):1871-9.
PMID: 26990290
PMC: 5779863.
DOI: 10.1002/cncr.29986.
UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO.
Goyama S, Schibler J, Gasilina A, Shrestha M, Lin S, Link K
Leukemia. 2015; 30(3):728-39.
PMID: 26449661
PMC: 4775400.
DOI: 10.1038/leu.2015.275.
Mouse models for core binding factor leukemia.
Chin D, Watanabe-Okochi N, Wang C, Tergaonkar V, Osato M
Leukemia. 2015; 29(10):1970-80.
PMID: 26165235
DOI: 10.1038/leu.2015.181.
A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.
Ratner N, Miller S
Nat Rev Cancer. 2015; 15(5):290-301.
PMID: 25877329
PMC: 4822336.
DOI: 10.1038/nrc3911.
Chemical biology. A small-molecule inhibitor of the aberrant transcription factor CBFβ-SMMHC delays leukemia in mice.
Illendula A, Pulikkan J, Zong H, Grembecka J, Xue L, Sen S
Science. 2015; 347(6223):779-84.
PMID: 25678665
PMC: 4423805.
DOI: 10.1126/science.aaa0314.
